UNITED STATES
           SECURITIES AND EXCHANGE COMMISSION

                  Washington, D.C. 20549

                       FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR
     15(d)OF THE SECURITIES AND EXCHANGE ACT OF
     1934 For the Quarter ended December 31, 2001

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d)
     OF THE EXCHANGE ACT
     For the transition period         to
                               ------    ------

       Commission file number -  000-28787

              Micro Laboratories, Inc.
       (Exact name of Registrant as specified in its charter)

  NEVADA                           05-049-4587
 (State or other  (Primary Standard Industrial    (I.R.S. Employer
jurisdictions      Classification Code Number)  Identification number)
of incorporation
or organization


29 Lakeside Drive,
Johnston, Rhode Island                02919
 (Address of principal executive offices)            (Zip Code)

       Telephone:  (401) 949-3562
    (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1)
has filed all reports required to be filed by
Section 13 or 15(d) of the Securities and Exchange
Act of 1934 during the preceding twelve months (or
such shorter period that the Registrant was
required to file such reports), and (2) has been
subject to file such filing requirements for the
past thirty days.

Yes    x      No
    ------       ------

Indicate the number of shares outstanding of each
of the issuer's classes of common stock, as of the
close of the period covered by this report:

    11,338,000 Shares of Common Stock
               (Title of Class)


Transitional Small Business Disclosure Format
(check one):
    Yes           No    x
       -------       -------

<PAGE>2
             Micro Laboratories, Inc.

PART I:  Financial Information

         ITEM 1 - Financial statements

         ITEM 2 - Management's' discussion and
                    analysis of financial
                    condition and results of
                    operations

PART II:      Other Information

         ITEM 6 - Exhibits and Reports on Form 8-K








<PAGE>3

PART I
Item 1. Financial Statements:

               MICRO LABORATORIES, INC.
            (A Development Stage Company)
                     Balance Sheet
               December 31, 2001 and 2000
                      (unaudited)
                          ASSETS
<TABLE>
<CAPTION>
                                                2001                   2000
                                            --------------------------------

                                              <c>                    <c>
Current Assets
  Inventory                                         0                 27,040
  Prepaid expenses                              3,000                 20,033
  Loans and exchanges                               0                 27,664
                                             --------              ---------
Total Current Assets                            3,000                 74,737

Property and Equipment
  Machinery and equipment                      47,070                 47,070
  Computer software                                 0                 11,723
  Furniture and fixtures                        3,664                  3,664
  Leasehold improvements                        2,357                  2,357
                                             --------              ---------
                                               53,091                 64,814
Less accumulated depreciation                 (26,743)               (17,791)
                                             --------              ---------
   Net Property and Equipment                  26,348                 47,023

Other Assets
  Deposits                                        600                    600
  Formulas and trademarks
     (net of accum.amort.)                      1,000                 60,600
                                            ---------              ---------
    Total Other Assets                          1,600                 61,200
                                            ---------              ---------
Total Assets                                  $30,948               $182,960
                                            =========              =========
</TABLE>





<PAGE>4

        MICRO LABORATORIES, INC.
      (A Development Stage Company)
             Balance Sheet
       December 31, 2001 and 2000
             (unaudited)
              continued
<TABLE>
<CAPTION>

LIABILITIES & EQUITY

                                                   2001                2000
                                                 ----------------------------

                                                 <c>                 <c>
Current Liabilities

Accounts payable-trade                         $ 366,188            $ 265,197
Accrued legal settlement                          65,000                    0
Due to related parties                           210,162              187,192
                                                --------             --------
Total Current Liabilities                        641,350              452,389


Stockholders Equity
  Common stock                                    11,338               11,338
  Additional paid-in capital stock             2,058,345            1,531,345
  Accumulated deficit                         (2,680,085)          (1,812,112)
                                              ----------           ----------
  Total Stockholders Equity                     (610,402)            (269,429)

Total Liabilities & Equity                      $ 30,948            $ 182,960
                                              ==========           ==========
</TABLE>




<PAGE>5

     MICRO LABORATORIES, INC.
  (A Development Stage Company)
       Statement of Income
    For the Nine Months Ended
   December 31, 2001 and 2000
         (unaudited)
<TABLE>
<CAPTION>
                                          2001             2000
                                       --------          --------

                                       <c>               <c>
Revenue
Sales                                 $     500          $       0

Operating Expenses
  Advertising                             3,000                  0
  Depreciation expense                    2,984              1,559
  Insurance expense                       1,265              1,264
  Auto                                    6,469              4,505
  Bookkeeping service                         0              2,000
  Consulting                            534,400                450
  Legal and accounting                    5,650             40,836
  Office expense                            432              3,481
  Dues and subscription                       0                 77
  Postage                                   796                344
  Printing                                  922              3,135
  Professional fees                       3,500                900
  Rent                                    1,962                780
  Office supplies                         1,043                125
  Service expense                         5,000                500
  Supplies                                  700                  0
  Telephone                               5,898              4,510
  Travel                                      0              2,456
  Utilities                               3,279                403
  Miscellaneous                               0                 30
  Licenses                                  385                200
                                        --------            ------
  Total Operation Expenses               577,785            67,555

Loss from Operations                    (577,285)          (67,555)
</TABLE>





<PAGE>6

     MICRO LABORATORIES, INC.
   (A Development Stage Company)
       Statement of Income
    For the Nine Months Ended
   December 31, 2001 and 2000
          (unaudited)
           continued
<TABLE>
<CAPTION>
                                          2001             2000
                                       --------          --------

                                        <c>             <c>
Other Income
  Loss on assets                             0                  0
  Interest income                            0                  0
                                       --------          --------
  Total Other Income                         0                  0
                                       --------          --------
    Loss before Income Taxes          (577,285)           (67,555)

Provision for Income Taxes
  Provision for state income taxes            0                 0
                                       --------          --------
  Total Provision for Income Taxes            0                 0

 Net Loss                             $(577,285)         $(67,555)
                                       ========          ========

</TABLE>









         MICRO LABORATORIES, INC.
       (A Development Stage Company)
          Statement of Cash Flows
     For the Nine Months Ended December 31, 2001
<TABLE>
<CAPTION>

                                                     2001               2000

                                                   <c>                <c>
Cash flows from operating activities:
  Net loss                                       $(577,285)          $(67,555)
  Adjustments to reconcile net income to
    net cash used for operating activities.
  Value of services received in exchange for
     common stock                                        0                   0
  Depreciation and amortization                      2,984               1,559
  Loss on sale of equipment                              0                   0
 (Increase) decrease in assets:
   Inventory                                             0                   0
   Deposits                                              0                   0
   Prepaid expenses                                      0                   0
 Increase (decrease) in liabilities:
   Accounts payable                                  1,000               4,335
   Notes payable                                         0              62,361
                                                  --------             -------
   Net cash used by operating activities            (3,984)                  0

Cash flows from investing activities:
  Gain on sale of asset                                  0                   0
  Acquisition of property and equipment(net)             0                   0
  Repayment from loans to related parties                0                   0
                                                  --------            --------
    Net cash used for investing activities               0                   0

Cash flows from financing activities:
  Issuance of common stock                         527,000                   0
  Amounts due to related parties                    46,301                   0
                                                  --------            --------
  Net cash provided by financing activities        573,301                   0
                                                  --------            --------
Net increase (decrease) in cash during the period        0                   0

Cash balance, beginning of period                        0                   0
                                                  --------            --------
Cash balance, end of period                        $     0            $      0
                                                  ========            ========
</TABLE>



<PAGE>8

Note 1.    In the opinion of management of Micro
Laboratories, Inc., the unaudited financial
statements of Micro Laboratories, Inc. for the
interim period shown, include all adjustments,
necessary for a fair presentation of the financial
position at December 31, 2001, and the results of
operations and cash flows for the period then
ended.  The results of operations for the interim
periods shown may not be indicative of the results
that may be expected for the fiscal year.  These
statements should be read in conjunction with the
financial statements and notes thereto included in
the Company's Form 10-K for the year March 31,
2001.





<PAGE>9
              Micro Laboratories, Inc.

PART I (cont.)

Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations:

Trends and Uncertainties. Demand for Micro's
products will be dependent on, among other things,
general economic conditions, which are cyclical in
nature.  Inasmuch as a major portion of Micro's
activities is the receipt of revenues from the
sale of its products, Micro's business operations
may be adversely affected by its competitors and
prolonged recessionary periods.

Capital and Source of Liquidity.   Micro currently
has no material commitments for capital
expenditures.

For the nine months ended December 31, 2001 and
2000, Micro did not pursue any investing
activities.

For the year ended March 31, 2001, Micro did not
pursue any investing activities.

For the year ended March 31, 2000, Micro acquired
property and equipment of $15,469 and received
proceeds from the sale of equipment of $9,825.  For
the year ended March 31, 2000, Micro received
repayment of $261 from related parties.   As a
result, Micro had net cash used for investing
activities of $5,383 for the year ended March 31,
2000.

For the nine months ended December 31, 2001, Micro
received $527,000 from the issuance of common stock
and received $46,301 from related parties,
resulting in net cash provided by financing
activities of $573,301.

For the nine months ended December 31, 2000, Micro
did not pursue any financing activities.

For the year ended March 31, 2001, Micro received
proceeds no from the issuance of its common stock.
As a result, Micro had net cash provided by
financing activities of $0 for the year ended March
31, 2001.

For the year ended March 31, 2000, Micro had
amounts due to related parties of $15,800 resulting
in net cash provided by financing activities of
$15,800.

<PAGE>10

On a long-term basis, liquidity is dependent on
commencement of operations as discussed above,
receipt of revenues, additional infusions of
capital and debt financing.  Micro believes that
additional capital and debt financing in the short
term will allow Micro to increase its marketing
and sales efforts and become a fully operational
corporation thereafter resulting in increased
revenue and greater liquidity in the long term.
However, there can be no assurance that Micro will
be able to obtain additional equity or debt
financing in the future, if at all.

Results of Operations.

Micro is accurately classified as a development
stage corporation and has conducted startup and
development operations that include:
  -   completed photo shoots, created corporation
logos, brochures, sales literature, product labels
and packaging design, UPCs
  -   prepared the product line of six items for
distribution roll out
  -   completed negotiations with three large
distributors to include  west coast, mid west, and
New England to represent and sell the companies
product lines to national chains.

Micro has not received any material revenues since
inception.

For the nine months ended December 31, 2001, Micro
had a net loss of $$577,285.   Operating expenses
for the nine months ended December 31, 2001 were
$577,785 and consisted of depreciation expense of
$2,984, insurance expense of $1,265, auto expense
of $6,469, advertising expense of $3,000, legal
and accounting expense of $5,650, consulting
expense of $534,500, office expense of $432,
postage of $796, printing of $922, professional
fees of $3,500, rent of $1,962, office supplies of
$1,043, service expense of $5,000, supplies of
$700, telephone of $5,898, utilities of $3,279 and
licenses of $385.

For the nine months ended December 31, 2000, Micro
had a net loss of $67,555.   Operating expenses
for the nine months ended December 31, 2000 were
$67,555 and consisted of depreciation expense of
$1,559, insurance expense of $1,264, auto of
$4,505, bookkeeping service of $2,000, consulting
of $450, legal and accounting of $40,836, office
expense of $3,481, dues and subscription of $77,
printing of $3,135, postage of $344, rent of $780,
professional fees of $900, office supplies of

<PAGE>11

$125, service expense of $500, telephone of
$4,510, travel of $2,456, utilities of $403,
miscellaneous of $30 and licenses of $200.

For the year ended March 31, 2001, Micro had
operating expenses of $206,070 and had a net loss
of $358,242 resulting in a loss per common share.
These operating expenses consisted primarily of a
legal settlement, write-off of obsolete inventions
and loss on impairment of assets

For the year ended March 31, 2000, Micro had
operating expenses of $1,144,851 and had a net loss
of $1,151,823 resulting in a loss per common share
of $.11.   These operating expenses consisted
primarily of advertising and public relations of
$371,976, legal and professional fees of $102,121,
fulfillment expense of $68,277, research and
development of $185,458, investor services of
$156,000, laboratory supplies of $2,435, telephone
of $17,663, depreciation of $8,661, amortization of
$5,050, rent of $26,265, automobile expense of
$14,235, travel expense of $3,713, website start up
expense of $108,550, office supplies o $4,695,
consult of $101,248, repairs and maintenance of
$2,033, postage of $1,511, bank service charges of
$806, printing of $119, dues and subscriptions of
$925, utilities expense of $936, directors
compensation of $10,000, distribution services of
$5,600 and miscellaneous expense of $574.

Plan of Operation.   Micro is in the development
stage and has not conducted any significant
operations to date or received any material
operating revenues.  Micro has experienced
problems, delays, expenses and difficulties
sometimes encountered by an enterprise in Micro's
stage of development, many of which are beyond
Micro's control.  These include, but are not
limited to, unanticipated problems relating to
additional costs and expenses that may exceed
current estimates and competition.

Micro is not delinquent in any of its obligations
even though Micro has generated limited operating
revenues.  Micro intends to market its products
and services utilizing cash made available from
the private sale of its securities and operations.
Micro's management is currently looking for an
acquisition candidate and is of the opinion that
the proceeds of the sales of its securities and
future revenues will not be sufficient to pay its



<PAGE>12

expenses for the next twelve months.   Advances
from its president will be required to continue
the minimal operations of Micro.



<PAGE>13

MICRO LABORATORIES, INC.

PART II


Item 6. Exhibits and Reports on Form 8-K

(a)   Exhibits (numbered in accordance with Item
       601 of Regulation S-K)

      None

(b)   Reports on Form 8-K

      None




               SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


/s/ Robert Thistle
----------------------------
Robert Thistle, President


February 19, 2002